Inspiring Tomorrow’s Leaders: Celebrating Kuwaiti Success Stories in Science and Innovation
In this special issue of Al-Taqaddum Al-Ilmi, the Kuwait Foundation for the Advancement of Sciences (KFAS) proudly highlights a groundbreaking research initiative led by Dr. Abdulmohsen Ebrahim Alterki and his team. They are pioneering new approaches to diagnosing and understanding Obstructive Sleep Apnea (OSA), a significant yet underdiagnosed health issue that impacts millions worldwide and can lead to severe health consequences, from cardiovascular risks to metabolic disorders. Current diagnostic methods are often invasive and challenging, discouraging many from seeking necessary treatment. Dr. Alterki and his team seek to address these challenges, aiming to develop non-invasive diagnostic methods using blood biomarkers. This approach could revolutionize how OSA is diagnosed, enhancing accessibility and allowing earlier intervention, which is essential for improving patient outcomes.
Supported by KFAS and carried out in partnership with the Dasman Diabetes Institute (DDI), a subsidiary of KFAS, along with international collaborators in Amsterdam, Dr. Alterki’s research exemplifies the power of global cooperation in addressing Kuwait’s healthcare priorities. Through this project, KFAS highlights the importance of international collaboration in advancing scientific research that tackles national and global health challenges. Such partnerships enrich Kuwait’s research landscape by infusing it with diverse expertise, perspectives, and innovative solutions, helping to position Kuwait as a valuable contributor to the global scientific community.
Dr. Alterki’s journey reflects KFAS’s mission to inspire future generations of Kuwaiti scientists by fostering curiosity and encouraging collaboration. As you explore this issue, we hope you find inspiration in the innovative spirit and dedication that are advancing Kuwait’s scientific community forward.
Together, we are shaping a future where science serves humanity, both locally and globally.
Ameenah Farhan
Director General
